Clinical Trial Update: Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil [NA]

View source ↗

Summary

The trial NCT02486848 evaluating the dose response of minoxidil in women identified as non-responders to 5% topical minoxidil has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Female Pattern Hair Loss

Drugs mentioned

• MINOXIDIL (Minoxidil)

Snippet

Sponsor: Maja Kovacevic, MD | Conditions: Female Pattern Hair Loss, Androgenetic Alopecia | NA | Status: WITHDRAWN